0001104659-14-052968.txt : 20140723 0001104659-14-052968.hdr.sgml : 20140723 20140723154136 ACCESSION NUMBER: 0001104659-14-052968 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20140722 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20140723 DATE AS OF CHANGE: 20140723 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MAGELLAN HEALTH INC CENTRAL INDEX KEY: 0000019411 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 581076937 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06639 FILM NUMBER: 14988758 BUSINESS ADDRESS: STREET 1: 55 NOD ROAD CITY: AVON STATE: CT ZIP: 06001 BUSINESS PHONE: 4109531000 MAIL ADDRESS: STREET 1: 55 NOD ROAD CITY: AVON STATE: CT ZIP: 06001 FORMER COMPANY: FORMER CONFORMED NAME: MAGELLAN HEALTH SERVICES INC DATE OF NAME CHANGE: 19960226 FORMER COMPANY: FORMER CONFORMED NAME: CHARTER MEDICAL CORP DATE OF NAME CHANGE: 19920703 8-K 1 a14-17607_18k.htm 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15 (D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported):

July 22, 2014

 

MAGELLAN HEALTH, INC.

(Exact Name of Registrant as Specified in Charter)

 

DELAWARE

 

1-6639

 

58-1076937

(State or Other Jurisdiction

 

(Commission File

 

(IRS Employer

of Incorporation)

 

Number)

 

Identification No.)

 

55 NOD ROAD

 

 

AVON, CONNECTICUT

 

06001

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (860) 507-1900

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENT OF CERTAIN OFFICERS.

 

(d)

 

On July 22, 2014, the Board of Directors of the Company appointed Kay Coles James as a director for a term ending at the 2015 annual meeting of shareholders of the Company. She was also appointed to the Compensation Committee of the board.

 

Ms. James is the President of the Gloucester Institute, a non-profit organization focused on developing future leaders.  From June 2001 to January 2005, Ms. James served as Director, U.S. Office of Personnel Management, where she was principal human resources advisor to President George W. Bush.  She has also served as Secretary of Health and Human Resources for the Commonwealth of Virginia, where she was responsible for Medicare and Medicaid programs; Senior Fellow at The Heritage Foundation; and Assistant Secretary of the U. S Department of Health and Human Services.  She currently serves on the board of trustees of The Heritage Foundation, as a member of the national advisory board of The Salvation Army, on the board of directors of The PNC Financial Services Group, Inc., and on the board of directors of Cancer Treatment Centers of America.  She also served as a director of AMERIGROUP Corporation from 2005 to 2012.

 

In connection with her appointment to the board, Ms. James received an award of restricted stock of the Company pursuant to the 2011Management Incentive Plan equal to $125,000 divided by the closing price of a share of Common Stock of the Company on NASDAQ on July 22, 2014 (the” Closing Price”) prorated for the period from the date of her appointment to the expected date of the 2015 annual meeting of shareholders of the Company. As a result, Ms. James received a grant equal to $l03,767 divided by the Closing Price, or 1,642 shares of Company Common Stock.  Such restricted shares shall vest on the date of the 2015 annual meeting of shareholders.

 

Attached and incorporated herein by reference as Exhibit 99.1 is a copy of the press release dated July 23, 2014.

 

Item 9.01. Financial Statements, Pro Forma Financial Information and Exhibits

 

(a)  Financial Statements of business acquired:  Not applicable.

 

(b)  Pro forma financial information:  Not applicable.

 

(d)                                 Exhibits:

 

Exhibit
Number

 

Description

99.1

 

Registrant’s press release dated July 23, 2014.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

MAGELLAN HEALTH, INC.

 

 

Date: July 23, 2014

By:

/s/ Jonathan N. Rubin

 

 

Name: Jonathan N. Rubin

 

 

Title: Executive Vice President and Chief Financial Officer

 

3


EX-99.1 2 a14-17607_1ex99d1.htm EX-99.1

Exhibit 99.1

 

GRAPHIC

 

NEWS RELEASE

Media Contact: Colleen Flanagan Johnson, cefjohnson@magellanhealth.com, (860) 507-1923

Investor Contact: Renie Shapiro Silver, rshapiro@magellanhealth.com, (877) 645-6464

 

Kay Coles James Joins Magellan Health Board of Directors

 

Avon, Conn. — July 23, 2014 — Magellan Health, Inc. (NASDAQ: MGLN) today announced that Kay Coles James, president of the Gloucester Institute, a non-profit organization focused on developing future African-American leaders, has been appointed to the Magellan Health board of directors. James was appointed to a term ending at the 2015 annual meeting of shareholders. James will sit on the management compensation committee of the board.

 

“Kay Coles James’ extensive experience working in senior leadership positions in both federal and state government, as well as her strong non-profit, academic and financial services experience will be an asset to Magellan Health during this time of expansion and growth,” said Barry M. Smith, chairman and chief executive officer of Magellan Health. “Kay is a strategic thinker, whose management and leadership skills are an impressive part of what she’ll bring to Magellan. I look forward to working with her more closely in the weeks and months ahead.”

 

From June 2001 to January 2005, James served as the director of the U.S. Office of Personnel Management, where she was the principal human resources advisor to President George W. Bush. In that capacity, James oversaw $650 billion in federal retirement, health, life and long term care insurance assets. She has also served as the secretary of Health and Human Resources for the Commonwealth of Virginia, where she was responsible for Medicare and Medicaid programs; senior fellow at The Heritage Foundation; and assistant secretary of the U. S Department of Health and Human Services. She currently serves on the board of trustees of The Heritage Foundation; as a member of the national advisory board of The Salvation Army; on the board of directors of PNC Financial Services Group, Inc.; and on the board of Cancer Treatment Centers of America.

 

About Magellan Health: Headquartered in Avon, Conn., Magellan Health, Inc. is a healthcare management company that focuses on fast-growing, complex and high-cost areas of healthcare, with an emphasis on special population management. Magellan delivers innovative solutions to improve quality outcomes and optimize the cost of care for those we serve. Magellan’s customers include health plans, managed care organizations, insurance companies, employers, labor unions, various military and government agencies, third party administrators, consultants and brokers. For more information, visit MagellanHealth.com.

 

###

 


GRAPHIC 3 g176071mmi001.jpg GRAPHIC begin 644 g176071mmi001.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T- M#AT5%A$8(Q\E)"(?(B$F*S7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#.2=K9Q,DG MELIR&SC%2ZBESXG,=U;I'YD">7)EMN[G((_.L!G9SEV+'W-=5H0^RP0@\;Q\ MWXU>/KNI3?*M3ULOPDZ+E*,KNWR.>ET?4[8[FM)1CD,@SC\JZ;0?$)N-MEJ! M*7`X1V&/,]C[_P`ZVJANO+$+-(BOCIN&>:\3#8NHZBC&-V]"<=.E6H/VRV5[ M]CJ`RI&NX@<#K65XCOQ'H=P%9E0@!W`R0I//%4]-U/[1B&=OWH^ZQ_B_^O5N M]MQ=V,]N>DL;+^8K>CDWU&MSRDW)?=_P3+"59CLOK85\RUCW[>I@16DEK=I<7,+QQQ`EF*G'M4 M5[K,L^4@S''Z_P`1_P`*]#@,%E:&:[ECB5^ID(`Q^-MNIE:/IIO[G=(/W$9RQ_O M'TKK@```!@#H!7'_`/"4RZ2BVJZ:FQ>C>8?G]^E-/CNX[:?%^,AIXO!XRO4O MRZ+;5'H8)X?#4[7U>^C.V@E,$RR#^$\^XK;N+@1VWF*?O#Y:\L/CN[_Y\8/^ M^FJ];^+;_4;14(C@V$@;.3CZFN2&1U:M:#J))+?4Z*^.A[-J#U9UK&L#5WTW6C';>2TDNX!)A\I3_`!'M66\CRMND=G;U8YJWI$>_48S_`'06 MKZJI1C1I2J-ZI-GCT:2E-)D9T\QY5&'![BF&UF'\(/T-:U['LN2>S(+1$]W8DUJZ99W?B#1S/J$H^^6M5"X5#T+8]^GX5R&G64FHW\-I'UD M;!/H.Y_*O5((8[:".")=L<:A5'L*Z\+2C3ESQ6QEB*5+EY+;G!SP2V\S0RH5 MD4X(KVO3(/LVEVL&,>7"B_D!7(W'AF363$_E&-D8$2,,`KGD>]=N.!BO6KUE M4C'N?-.A[&;2=T+24M8?C!KA/#TQ@)'S*)".NW//]*Y6:TJ?M*BA>UV2ZAXG MTK3\J]P)9!_RSB^8_P"`K*L?&_4R_#X>A*-A,3+#55-?/T(M.G%UIMM<`Y\R M)6_,4Z*]MIKB2WBG1YHOOH#RM06=NFCZ0(2Y:.V1L,>NT9(S^%>:VVJW%KJO M]HQ-^]+EV!Z,">0:[\)A77BWU7YGC9CCX86I%)73;^X]8HJKIU_#J=E'=P'* MN.1W4]P:M5RM.+LSMC)22E'9F3XFU==#\/W=_D;T3;$/5SPOZUX`S,[%W)9F M.23W->]>*?#4?BC3H[.6ZDMA'*)`R`'/!&"#]:S=.^&GARQPTT$EZX[SOD?] M\C`K"I"4F>O@\31H4W?=GC5O;SW8[@^W3&>:Z:UL[6RB$5K;10(/X8T"C]*GIPI\KO]/K7%NACD9#U4D'\*$1I76-%+,QPJCJ34)V/LL1AJ6( MC::^9[$"&`(((/0BO,/B3=>;K\5N#Q!`,CW8D_RQ7HFDVTMGI-K;SMNDCC"L M<]ZXVX\(7NO>+[RZOU:"Q60`-GYI5```7T'O751:3NSY?#.%.JY-Z*YS/AOP MQ=^(;GY(Q,JS\CC?B3-MTBTAS_K)\_DI_QKSN*5X)4EB8K(C!E8 M=B.E=M\3)LW%A!_=1W_,@?TKC;2SN+^Y2VM86EE?HJ_YX%>IADE15SR:NLSV M+0M436-(@O5X9UPZ^C#@C\ZT*RO#>D-HFBQ63WFZVTHM;P=#-T=_I_='ZUR0ED67S1(XD!SO#'=GUS7J M*^`M`7K;RM]9FJ=?!7AY?^8Z?_6KS\7A M.7WX;&%*M?W9'%>)Y=MK##G[[[C^`_\`KU@6[8DQZUI>))=^H)&#Q&@_,\UD M`[6!':O8RY>SHP?S/E\?6OC)2[:?<7Z]2\":7]@T!9W7$MV?,/KM_A'Y<_C7 MG.BZ>VKZK;6:9Q*XW$=EZD_E7M2(L<:QH`JJ``!V`KT\94]U174]&A&_O#J* M**\TZ@J"XO;6U&9YXX_8MS^5-O[>6ZLI(89C$[#AA7#7=I<6*;./(@228^N-H_6FZ5X@FU#4!;O`B(RD@J3D M8KE:WO"<.Z[GF(^X@4?4G_ZU<-'%5JM6*OH;SI0C!LZJBBBO:.(****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@#YOAC,TZ1C^)@*ZL#:`!QCI6!HT7F7N\CB-2?QZ5T%1-ZGV&"C:#EW- M>WD\V!7[XY^M5-1ERRQ#MR:+"8('1CQC<*J2.7=G8@$G/6GDV"2Q?Y?\`#_J-!(.0<$5O:9J?V@"&8XE'0_WO_KUSQEC'61?S MIOVJ)2"&;(]!7T6+JX2<>6NW< M6,+YA9?H>?ZU9TW29HK6359V>!(8R\8!PS$#CZ#^=;D=G!J]\FH72EGC0+L/ M1L=&-'BJ?R/#TX'!DVH/Q/\`@*^+J3OB%2AU:U/T7$8J4:-FK.VM_38Y87TV MH*)IYGEDZ,7;.#4D(S*OUK&LY_)FP3\C<&MNV&9,^@KZ*,$II+8_/9TFJR\R M6XMX[F(QR#CL>X-<]=6TEK*8W'^ZW8BNFJ*YMH[J(QR#Z'N#7?.',>DAZ5TFE/%::;+=3R+'&&)9V.``*YLRK7P4K;NR.W+I*K M43[%K44S$)/[IY^E8$TIE?/\(Z5GW'C+^T->M((U*::)@L@/!E!XR?0_U.H^'_AJWFEN;QI2IP%1<Y M!^M>B6^G6MMS'$"W]YN37'>'IUTV_@4'$9'EM]#W_.N[KSL/6C43Y=D_PZ&6 M(JU9/WV%%%%=)R!4-W;I=VDMM(,I*A4_C4U%`TVG='C]Q`]M<202##Q,5;ZB MN[\#6GDZ.]P1\UQ(2/H.!^N:Q/&VGFWU9+I%^6Z7M_>'!_I7:Z9:BRTRVM@, M>7&`?KW_`%J(K4]_'XE5,+!K[7Z;_B6Z***L^?,3Q==_9?#\X!PTQ$8_'K^@ M->:UU_CZ[S-:V8/W09&'UX'\C7(5]'E\.6BGW/C,XJ\^*:_ET-OPQKITB]\N M9C]EF.'']T]FKTD$,H92"#R".]>-UWW@C4+BZT^6VF!9+8@1N?0]OP_K7-F. M'5O:KYG9DV,?-]7EMT.GHHHKQ3Z<*@CF)E96]>*FJAGG-7%7,YRM8T*BN8O. MA*#KU%+%)YB9[CK4E0UT9>Z&J-J!?08IU%%`SRK78/L^N7D>,`2DCZ'G^M=+ MX,T'8HU6Z3YB/W"GL/[W^%6]0\*G4?$8O977[*P4NG\3$<8^AXKI%4*H50`` M,`#M4*.I[6*QZE0C3@]6M?\`(6BBBK/%"BBB@#BO%GAO4]=\0VY@55MA"%:9 MCPO)SQU)YKHM$T"RT*V\JU3,C#]Y,WWG/^'M6G16LJLG%0Z(A02=PHHHK(L* M***`"BBB@`HHHH`*0@,""`0>H-+10!R6J?#K2=1N9+A)KBWDD.3M8%1^!%8- MU\*[I"?"=WH=S<7&HB(R[?+B M,;;ACJ3_`"KL:**1"C2OG!&#CM_6MFBN6GA(4ZG/ M'[C:564H\K"BBBNLQ"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`\,\/6,\L#R1Q,Q=L`@<8'O720:$Y MP;B0+_LIR?SK/L-9^P7TD+#_`$0N0%`^YVR*Z62XBBMFN6<>4J;RP/&*J=&4 M;2EU/?P^/]I#EIZ6^\Y/Q;K2E*GJ]S=J:WA\Q\G[ MHZ^]5K.&_:(M/;2K&H_UK+@?C6G$8@@5'4@>]9T:#D[VT1TO$TGIS*_:YZM;P0J7*0@X';)__ M`%5TTJ/-BX2]3Y_.URT^===#FJZ+1X+F:S,K1':"%#'O4-GI4<.'GQ(_IV'^ M-=CIMJO]EJC#_6?,?Z5ZN-Q'U2FJCWO8^9PF'A7JI5-EV,(V\H_@--,;CJC? ME6I(C1R%&Z@TVB.82:O9'TCR"BU>,W^#_P`C&NK5+F(QR*1Z''(-9MG:RP3R M0LI+$C;M&=WTKJ\9.,9)K8TZ,V)$J!1*>IQ^E$M6O<.T0M8^N^;@_EUK,\8Z+J\-M'Y4OVG3X1DK&N"I[LP[_7 MM7IEO>MJJSVUHF^XA`\Y5(^4'./SP>*@DL+R+[]K*H_W#7#@ZN(Q$7.NK*^B M_4\>=*.#ERTKON_T/!`2.0>1R#7N&GRQ:SH-M+*H=+B%2P]\<_K7*>)?`T5V M7NM,5;>YZM">$D^GH?TK5\`RS?V`UC<(T<]E,T;(PP0#R/YFNY7BSU<#6A4; MCWZ%#5-+DTV?!RT+?+S%5:$J--WEUMV_K0:P2CB$X[=%YFI7>:5=_;= M-AF)RV-K?4=:\RAU_2Y_NW:J?1P5_G77^$-1B>26U65'5QO3:P/(Z_Y]J\;! M2E3J\LEN=.(IRY;M;'54445[AYP4444`5KS3[6_6,7,0D$3B1/8BK-(2`,G@ M5R'B'QW;V.^UTO;<7`X,O5$_^*/Z5$YQ@KR.BC1JXAJ$%?\`)'845Q_@/6K_ M`%07J7UP9S&59"P&1G.1QVXKL*(34X\R%B*$J%1TY;HXGQ%X=U;4M=DFAA5X MF"A'+@``#H?QS1:>`9#@WEZJ_P"S$N?U/^%=M17H+'5E!0CI8\5Y5AI5'4FF MVW?/]T?UKUA$2*-8 MT4*BC"J!@`5Z&-J)Q]F88;GA+VD78\J/A:PT^8Q367[Q?^>I+?\`UJN10Q0C M$421C_94"O0KW3[?4(O+G3/]UAU7Z&N1U/1;C3B7QYL':0#I]?2ODL3AJD-; MW1[$<0ZFDGJ<_K,FW3V&>78"N=K:UY_W<,?J2U<_+<`?*G)]:^DRBU+!J3ZM MO]/T/%S"K&-5WZ$KW!AZ,<^@-9W]J[;^1;@##8&\=1QW]JD)).3R:Q;DYN9# M_M&NQ5'*?,>;2KSJ2:;T['4Q+YSHJ'.\@`CWKKD4(BH.BC`K&\!^#M5N[9M4 MN,PVBJ6@C=?FE/J/0?SKHS9MV@KCP;JI>SG%^6A]'A\ M5&E3:JNR1;M8XX8C=W#*B*,@L<`>]<[K7C!Y=UOI9*)T,Y')_P!WT^M8NJZW M=ZO)^^;9"OW(4^ZO^)K/KU*.7IR]I7U?;HO\SYG&YE.O-\NB/9/@_9F/P]=W MSY+W5R1N/4A1C^9->@U@>!;'^S_!>F0E<,T(D;ZM\W]:WZTF[R9C!6BAKQI( M,.BM]1FN4U:[@MM998((U55"R%%`+'_ZU=/=W"VEK+._2-2?K7G\DC2R-(YR MSDDGW->1F4_<]GW.S#P][F.B1UD0.ARIZ&L#4+:&]$T%P@>-R<@_SJ2TOQ9D MF5@(>K$GA?>GR03?ZWRGV/\`,K;3@@]#7'DM!TZE2^UD<^9R:4''<\WUG19M M)GYR\#G]W)C]#[U)X5N&M?$ME)&Q0[]N1[@BNZN+>&Z@>"=`\;C!4UQEUI$N MA:Q:SJ2]MYZE)/3GH?>O9G2Y'S+8]3+LS6)C[*K\7Y_\$]FTW5ENL1386;L> MS5IUQ8SNPNO%MNHB`!\KMP3]16YS8B@H^]$T****#C/+_%GBG4 M;V\GT\*]I;QL4,?1I,=R?3VKEZ]NO=-LM1CV7EK%.O\`MKDCZ'M7,:C\.;"? M+V%Q):MV1OG3_$5Y]7#U)/FO<^EP>9X:G!0<>7\?^"9WPT;_`$R_7UC0_J:] M"KF/"7A6X\/S7$US<1R/*H11'G``.3F-6%7$RG!W6GY!11 M16YP!1110`4444`(0&!!Y!I@@C'\.?K4E%.[%9,0*!T`%+112&%%%%`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M1110`4444`%%%%`!1110!D>)O$EGX5TK^T;V.:2+S%CQ$`6R<^I'I6?X6\?Z M-XMNIK6R$T,\2[_+G4*77N1@G./ZUD_&3_D1Q_U]Q_R:O(M,DU'PU-I7B2#[ MCR/Y9'1MIPZ'Z@_K0,^FJYSQ5XXTGPBT$=_YTLL^2L4*@L%'_/Z&@1[SX6\56 M7BVPEO;&*:..*7RB)E`.<`]B?6MNO./@H0/"UZ3P/MA_]`6NDO/B!X3L)V@G MUNW\Q3@B/+X_%0:`.CHK.TC7])UZ%I=+OX;I5^]Y;3J6JP02XSY>2S#Z@9(J71_$FC:^K'2M M1ANBG+*APR_4'F@#+\2^/])\+:G#I]]#=/+-&)%,2`C!)'7$=O"EM'NDE8*H^4=S65_PLGP= MYOE_V[!G.,[7Q^>,4".HHJH=4L1IC:F+J-[-8S(9D.Y=HZGBLA/'_A.2V>X7 M7;3RT."2Q!S[`C)_"@#HJ*PM*\:^&]:NA:Z?JT$TY^[&]+ M12`Y37?`5KJ\GFP7L44XO ME5ELUG3\FZTRX11_$$W+^8XKH/`WPV-S(NL:_"1&3O@M M''+>C/[>WYUZ=>7!MX-RXW$X6G6LWGVZN>O0_6LUC(^U=!/WK7%1P*I7G>Z) M0`JA5```P`.UJFI6GVNS9`/G7YD^M6>C0JT#Q/QC M\-;S0M]]I8>[T\_J/>N+L[=KR\@MDY:>18Q^)Q7U!7)7?P]TI_$UG MKEF!:R0S"6:%5^24CH0.QSBNB%?2TCQYT=;Q.IAB6"".%!A8U"J/8#%244A. M!DUS'2<_XKO-D,5HIY<[V^@Z?K_*N+U+5K328?,N9,$_=C7EF^@JEXO\=0OJ M,XTXK/)G:).J(!QQZFN`N+B:ZF::XE:21NK,:XX8">)JNI4TCT[O_(N>*C2C MRPU9J:EKUWK=PL3'RK#]?6O;?`]_\`VAX4M&)R\(,+?\!X'Z8KP.P3 M=<@_W037J_PKO_FOM.8]=LR#]#_[+7ISIPIQ4(*R1Y4:\GB4I/='H$EO!+_K M(8W_`-Y0:IW.@:5=Q-%-9QE6Z@9%:-%8'H\JO>Q!;V=O:C$,2K[]3^=3T44% M-MN["BBB@04444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110!P7QD_Y$1^ M*YKIOC)_R(X_Z^X_Y-4GPD19/A_$C@%6FE!![C-`'G,/BYX_A1+H?F_OC=^4 MO//DD;S^H(_&MXZ$-&^!MU,Z8N+]HKB0D7NQNSTQBO6?B=$D/PXOHHU"H@B50.P#KB@9B_!N(7'@[4H22 M!)=.I([9115*XT#X5:`WV+4+TSW*<.?.=V!]]G`^E8WAW5;K2/A!K,]F[1S2 M7PA$B]4#*H)'X9_.M+X9>!/#^NZ$^IZI']LF:5D\KS"HC`]0"#D]>:`,'PS< M66F?%:U3P]=/+I\TXB5CGYD9>5.>N#Z^E7?%OG>+OBPFB75PT5M',MN@!^XN MW+$>YY_2H8K'3],^-%K9Z6BI:17<815SO&AU M*XPSPIU&W@2`]CP![XH`VO&'PP\.V'A2[O=.BDMKFSB,@=I68/CJ&!]?:N>^ M'CVFD>%-=\3)"W]HV*&*-RYVD,!@;?\`>J8Z3\2_%^EQ6MU>PM82A2S&:,`C MJ-VSD_2NLNO!":)\+M2T:S8W%S)$9I9,8,CC!X'IA<`4`<3\._"VE^*7O]5\ M17)EQ+M"/-L,CD99F..+&]T&Y)@(64*)-VT9PR$]P1Z^M4? M`GAC1/%-Q<6FI:G+9W*@-`JE0)1WZ]QQQ[UVT_P<\.VBJUQKUS"&(`WM&N2> M@&10!B?&%Q)XPTUUZ-9QD?\`?;58^-__`!_:1_U[R?S%5OC!&(O%VFQ@\)9Q MJ,^SM5GXW_\`']I'_7O)_,4`=[JNA:;X@\&:?;ZM7*CRM\^..V#S4/Q3U2Z^PZ!I"R%+5K*.=QGAVQ@9 M]<8_6NI7X;>$+#PN]Q-`MS(ML9/MV$H9@N\ML="""" M>>_Z5[9IUPUWIMKHHHH`****`"BBB@`HHHH`****`"BBD;.TXZXXH8&1J$WFW!4'Y4X_'O4V ME2_,\1[_`#"J,D4L;'S$8'U(IUM+Y5PC]@>?I7P]+%3ACE6J:7>OIM^!Z+@G M3Y4;U%%%?<'G%6&VAM;F612`TQSCT_R:M54N?]8/I1%.4X;E?Y5?+I=$NHW+ MWBW1358,,JO(+VRNM.N MY+2]@>">,X:-Q@C_`.M[U]/5B>)?">E^*+3RKV+;,H_=7"U7S5D\Q4#'C/&#]:?X M3\.)X5T--+CNFN51V?S&4*3DYZ"MJB@`K)\3Z"GB70+C27N&MUGVYD5=Q&&! MZ?A6M10!R6A?#ZPTGPS>Z!=7#W]M>2%W+($(X`&,=Q@'-(Y( MH'ZAHB&QZ':P!KUBB@#S;3_@Y!IFHV=_:Z[<+/:NLGS0*0S`Y]>![53\;:9X M+U/QA)9:CJ&H6FK2B,>8BF2,DCY5Q@X[<<=:]5KRCXE>$=:7Q'%XIT.%[AEV M-(D8W/&Z=&V]Q@#\J!F;>?";Q/H;-,^_%4_^%L^*7@^SQ^&/]+(V[Q'(1GUVX_K5_X: M^"]6M]:F\3Z^C0W$@]`%KQ'\'M-U6]DO-,O&TZ21MS1 M;-\>[U`R"M5M'^#*6NH07>HZW+22SZO\`:;EG M*W9"^8^<#GIFH_#]]<&7Q',TS2F"5C'O;(&`V`/;BNAT&G)7VM^)RQQ*:B[; MW_`C\9_#NV\87UO>/J$MG+#&8SLC#;AG(Z],9-'BGX>Q>*[/3H[O4Y([BRC* M&=(@?-!`ZC/'3-4=%T6YU[34U*Y\0W<4LS-E%?@8./6NDUNZ_L/PG*T<[L\< M(BCE8Y8L>`<^O>B=%*2@G=WL*&(/S&+8!`)Z_4?E5VUN)V^(EY`TTAB6T!6,L=H^[V_&B5!QDU?97"&) M4HQE;=V]"CX6^',?A:YO9(-6EGCO(#"T;Q`;?0Y!ZCG\ZF\%?#^'P9=74\6H MR79N45"'C"[<'/8U4\::;+P:SP7)279'\R/ANHSS6 M[IS%M,M68DDPH23WX%8NFU#F\[&\:JE/D\KEFBBBLS4****`"BBB@`HHHH`* M***`"BBB@!.M1FWA+!C$F1WQ4M%3*$9?$KC3:V"BBBJ$5KH'<#CC%0B-VZ*3 M5^BK4[(S<+NY6BAD1@2<#N*LT45+=RTK!1112&%%%%`!1110`4444`%%%%`! M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444 M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'GN@^&K#7;O5)+PS!HKIE M7RWV\9-6?#%NEM:^);:+<4B9D7/)P`P%:_A=%2^UH(H4?:SP!BCPXBKK&NA5 M`!N1D`?6O2J5)/G3V5OT/*I4HKV;2U=_U.8\/Z)X;OM'BGU"_P#*N26#I]H" M8YXX/M6EXNC,L6D>'],Q)OPZ`MD%5&%R?3K^5.%#:J`TC!03A?6KWCA%;P_EE! M*S(5)'0^U8?CR&(S64AC0NT7S-M&3]365.U:U]+IK\C>K>AS6=[-/7SNC1\< MW$%UH%M+;S)+&;M`&1@PZ'N*G\??\BM)_P!=$_G7/P1I_P`($!L7B_!''3I7 M4^,D5_#%SN4-C:1D>XJ.7DG"/9O]"^?VE.I+O%?J#)@R@@0H<$?2JNH, MRG18PQ"21J'4'A@`,9'>H